EP
Esposito Pamela
Directeur Commercial
OtherF
Insider track record
ExecutiveAcross 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Esposito Pamela, Directeur Commercial. Director active across 2 companies, notably Replimune Group, Inc.. Cumulatively, 19 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €148k. History available since 14 January 2021. The latest transaction was disclosed on 2 December 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations19 total
2,500 shares@ US$29.5523.7% of flowCommon StockSEC:0000950170-24-132401:0
8,500 shares@ US$29.5576.3% of flowCommon StockSEC:0000950170-24-107458:0
5,358 shares@ US$3.303.8% of flowCommon StockSEC:0001104659-23-100560:0
13,600 shares@ US$3.309.6% of flowCommon StockSEC:0001104659-23-094997:0
1,400 shares@ US$3.301.0% of flowCommon StockSEC:0001104659-23-092111:0
15,000 shares@ US$3.3010.5% of flowCommon StockSEC:0001104659-23-080113:0
5,966 shares@ US$18.0523.1% of flowCommon StockSEC:0001104659-23-062372:0
40,000 shares0Common StockSEC:0001104659-23-041727:0
15,000 shares@ US$1.013.3% of flowCommon StockSEC:0001104659-22-126741:0
3,507 shares@ US$14.590.011% mcap23.5% of flowCommon StockSEC:0001104659-22-062610:0
22,750 shares0Common StockSEC:0001104659-22-042762:0
4,200 shares@ US$15.500.013% mcap26.4% of flowCommon StockSEC:0001104659-21-101719:0
4,200 shares@ US$15.5012.8% of flowCommon StockSEC:0001104659-21-101719
4,862 shares@ US$1.011.0% of flowCommon StockSEC:0001104659-21-095084
4,862 shares@ US$1.010.0010% mcap2.0% of flowCommon StockSEC:0001104659-21-095084:0
20,000 shares@ US$1.013.9% of flowCommon StockSEC:0001104659-21-093670
4,600 shares@ US$1.010.9% of flowCommon StockSEC:0001104659-21-093671
20,000 shares@ US$1.010.0039% mcap8.0% of flowCommon StockSEC:0001104659-21-093670:0
4,600 shares@ US$1.010.0009% mcap1.9% of flowCommon StockSEC:0001104659-21-093671:0
About Esposito Pamela
Pamela Esposito is the Chief Business Officer of Replimune Group, Inc. She is responsible for commercial strategy and product development. Her expertise in marketing and product management is essential to support the company's growth.